BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 10600358)

  • 21. The persistence of regulatory cells developing after rat spontaneous liver acceptance.
    Asakura H; Takayashiki T; Ku G; Flye MW
    Surgery; 2005 Aug; 138(2):329-34. PubMed ID: 16153444
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prolonged cold ischemia does not trigger lethal rejection or accelerate the acute rejection in two allogeneic rat liver transplantation models.
    Jin H; Dahmen U; Liu A; Huang H; Gu Y; Dirsch O
    J Surg Res; 2012 Jun; 175(2):322-32. PubMed ID: 21612794
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Donor-specific tolerance in fully major histocompatibility major histocompatibility complex-mismatched limb allograft transplants under an anti-alphabeta T-cell receptor monoclonal antibody and cyclosporine A protocol.
    Siemionow MZ; Izycki DM; Zielinski M
    Transplantation; 2003 Dec; 76(12):1662-8. PubMed ID: 14688512
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of donor gender on male rat recipients of small-for-size liver grafts.
    Gu Y; Dirsch O; Dahmen U; Ji Y; He Q; Chi H; Broelsch CE
    Liver Transpl; 2005 Jun; 11(6):669-78. PubMed ID: 15915489
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antidonor humoral transfer induces transplant arteriosclerosis in aortic and cardiac graft models in rats.
    Alkhatib B; Freguin-Bouilland C; Litzler PY; Jacquot S; Lallemand F; Henry JP; Thuillez C; Plissonnier D
    J Thorac Cardiovasc Surg; 2007 Mar; 133(3):791-7. PubMed ID: 17320586
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Trafficking of donor-derived bone marrow correlates with chimerism and extension of composite allograft survival across MHC barrier.
    Ozmen S; Ulusal BG; Ulusal AE; Izycki D; Yoder B; Siemionow M
    Transplant Proc; 2006 Jun; 38(5):1625-33. PubMed ID: 16797371
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Electroporation-mediated interleukin-10 overexpression in skeletal muscle reduces acute rejection in rat cardiac allografts.
    Tavakoli R; Gazdhar A; Pierog J; Bogdanova A; Gugger M; Pringle IA; Gill DR; Hyde SC; Genoni M; Schmid RA
    J Gene Med; 2006 Feb; 8(2):242-8. PubMed ID: 16389627
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Investigation of antibody-mediated rejection in composite tissue allotransplantation in a rat limb transplant model.
    Unadkat JV; Schneeberger S; Goldbach C; Solari MG; Washington KM; Afrooz PN; Pulikkottil BJ; Zheng XX; Lee WP
    Transplant Proc; 2009 Mar; 41(2):542-5. PubMed ID: 19328922
    [TBL] [Abstract][Full Text] [Related]  

  • 29. FK778, a powerful new immunosuppressant, effectively reduces functional and histologic changes of chronic rejection in rat renal allografts.
    Pan F; Ebbs A; Wynn C; Erickson L; Jang MS; Crews G; Fisniku O; Kobayashi M; Paul LC; Benediktsson H; Jiang AH
    Transplantation; 2003 Apr; 75(8):1110-4. PubMed ID: 12717186
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibody-mediated rejection of human orthotopic liver allografts. A study of liver transplantation across ABO blood group barriers.
    Demetris AJ; Jaffe R; Tzakis A; Ramsey G; Todo S; Belle S; Esquivel C; Shapiro R; Markus B; Mroczek E
    Am J Pathol; 1988 Sep; 132(3):489-502. PubMed ID: 3046369
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Organ transplant specificity of tolerance to skin grafts with heart or kidney grafts plus nondepleting anti-CD4 monoclonal antibody (RIB 5/2) and intravenous donor alloantigen administration.
    Otomo N; Margenthaler JA; Motoyama K; Arima T; Shimizu Y; Lehmann M; Flye MW
    J Surg Res; 2001 Jun; 98(1):59-65. PubMed ID: 11368539
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mixed chimerism achieved by a nonlethal conditioning regimen induces donor-specific tolerance to lung allografts.
    Li S; Salgar SK; Kurimoto Y; Yousem S; Pham SM
    J Surg Res; 2008 May; 146(2):289-97. PubMed ID: 18314139
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enteral feeding of glycyl-glutamine dipeptide improves the structure and absorptive function of the small intestine after allogenetic liver transplantation in rats.
    Jiang JW; Zheng SS; Xue F; Gao LH; Jiang GP; Xie HY
    Hepatobiliary Pancreat Dis Int; 2006 May; 5(2):199-204. PubMed ID: 16698575
    [TBL] [Abstract][Full Text] [Related]  

  • 34. FK778 controls acute rejection after rat liver allotransplantation showing positive interaction with FK506.
    Yamamoto S; Okuda T; Yamasaki K; Tanaka H; Takemura S; Minamiyama Y; Ikeda K; Hirohashi K; Suehiro S
    Transplant Proc; 2005; 37(1):126-9. PubMed ID: 15808570
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The efficiency of humoral immune transfer depends on both the graft and the immunosuppressive treatment.
    Dahmen U; Li J; Gu Y; Doebel L; Fan LM; Polywka S; Dirsch O; Broelsch CE
    Transpl Int; 2003 Mar; 16(3):161-7. PubMed ID: 12664210
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibody-mediated response in rat liver chronic rejection.
    Wan R; Ying W; Zeng L; Deng X; Chen H; Gao L
    Transplant Proc; 2011 Jun; 43(5):1976-9. PubMed ID: 21693310
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antiproliferative effects of NKH477, a forskolin derivative, on cytokine profile in rat lung allografts.
    Nakashima S; Morikawa M; Komatsu K; Matsuura A; Sato N; Abe T
    J Heart Lung Transplant; 2005 Apr; 24(4):462-9. PubMed ID: 15797749
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of risk factors for the development of GVHD after T cell-depleted allogeneic BMT: effect of HLA disparity, ABO incompatibility, and method of T-cell depletion.
    Keever-Taylor CA; Bredeson C; Loberiza FR; Casper JT; Lawton C; Rizzo D; Burns WH; Margolis DA; Vesole DH; Horowitz M; Zhang MJ; Juckett M; Drobyski WR
    Biol Blood Marrow Transplant; 2001; 7(11):620-30. PubMed ID: 11760150
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased immune responses to regenerating partial liver grafts in the rat.
    Omura T; Nakagawa T; Randall HB; Lin Z; Huey M; Ascher NL; Emond JC
    J Surg Res; 1997 Jun; 70(1):34-40. PubMed ID: 9228924
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 1 alpha,25-Dihydroxycholecalciferol reduces rejection and improves survival in rat liver allografts.
    Redaelli CA; Wagner M; Tien YH; Mazzucchelli L; Stahel PF; Schilling MK; Dufour JF
    Hepatology; 2001 Nov; 34(5):926-34. PubMed ID: 11679963
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.